DateTitleType of Article
03.08.2010Algeta concludes agreements for the manufacture and supply of Alpharadin for future commercial sale

Press Release
02.08.2010Pathwork Diagnostics Partners with Leading Pharmaceutical Company to Discover Molecular Diagnostics for Cancer

Press Release
19.07.2010MediGene sells full European rights for Eligard to Astellas for EUR 25 million and ongoing royalties

Press Release
24.06.2010MediGene reports additional phase II results of EndoTAGTM-1 for the treatment of triple receptor-negative breast cancer

Press Release
15.06.2010Micromet's Blinatumomab Induces Durable Remissions in Patients with Relapsed Non-Hodgkin's Lymphoma

Press Release